Insight journal - Company

Merck & Co: M&A activity 2005-2013

Posted on 22 April 2013

Tags: , ,

Merck & Co has announced 11 M&A deals since 2005, with the lead deals being the acquisition of SmartCells, Inpire Pharmaceuticals and in 2009 Schering-Plough.

Abstracted from: Partnering Deals and Alliances with Merck & Co

Merck & Co is involved in low levels of M&A activity when compared with its peers in the list of top pharmaceutical companies. Instead, the company appears to focus on internal, organic growth combined with extensive partnering or licensing. There have been occasional exceptions when Merck & Co has sought grow through strategic acquisition, for example when acquiring Schering-Plough in 2009 in a megadeal valued at $41 billion.

The following figure shows the level of Merck & Co M&A deal announcements since 2005.

Figure 1: Merck & Co M&A deals 2005-2012

Merck M and A per year

Source: Current Agreements, 2013

Merck & Co has signed 11 M&A deals since 2005. Companies acquired include:

  • Abmaxis
  • Avecia Biologics
  • GlycoFi
  • Novacardia
  • SmartCells
  • Schering-Plough
  • Sirna Therapeutics

View the full list at Current Agreements (subscription required)

Bayer has been attracted to acquisition transactions whereby the company expands through the acquisition and assimilation of strategic target assets to realize business growth. This is evidenced by the acquisitions of Schiff Nutrition to access the nutrionals market, and AgraQuest to grow its crop science business..

The following figure provides a summary of the top M&A deals by headline value.

Figure 2: Top Merck & Co M&A deals by headline value 2005-2013

Merck M and A  top deals

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Merck & Co

Merck & Co M&A at Current Agreements             

View all M&A deals for Merck & Co: 2013 | 2012 | 2011201020092008200720062005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Deals and Alliances with Merck & Co


Summary profile data for Merck & Co

Partnering interests for Merck & Co

Partnering activity for Merck & Co


Available reports from Current Partnering

Report: Partnering Deals and Alliances with Merck & Co

Report: Partnering Deals and Alliances with Big Pharma


Available resources for deal coverage for Merck & Co          

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Merck & Co company profile, recent partnering, M&A and financing news and articles



Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply